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Abstract 
Fetal alcohol Syndrome (FAS) and its wider spectrum of presentation Fetal Alcohol Spectrum 
Disorders (FASD)  represent a range of disorders that are sometimes difficult to recognise as they  
may present in a way that overlaps with other conditions. This makes identification and recognition 
challenging, which increases the burden associated with the disorder. When considering the 
reduction in morbidity, both prevention of exposure to alcohol by the fetus but also early 
identification of cases is required. This selective review seeks to highlight some of the complexities 
involved as well as highlighting the challenges. By considering populations particularly at risk to 
exploring the reality of alcohol risk it will seek to offer some solutions to begin the process of 
change.  
  
Introduction  
Prenatal alcohol exposure on the developing fetus has been demonstrated now for over 40 years to 
have both direct and indirect developmental impacts across the human lifespan1.Yet because such 
developmental outcomes and pathways have not yet been systematically attributed to the effects of 
prenatal alcohol on the fetus, such risks of morbidity largely tend to remain unrecognised and 
therefore neglected in intervention design and development, public health education, 
multiprofessional practice and service provision.  
Fetal Alcohol Syndrome (FAS) is the most easily recognised part of the spectrum of presentation. 
This however only represents a small proportion of the range of difficulties seen. Far more common 
are the neurological deficits, but due to timing of alcohol exposure the facial and physical 
characteristics are less evident. According to  DSM V framework (APA, 2013), the term 
Neurodevelopmental Disorder associated with Prenatal Alcohol Exposure (ND-PAE)2 has been 
proposed. This is a term that has yet to have wider utilisation, but increasing research is being 
conducted in order to identify and establish the utility of this diagnosis, with the term Fetal Alcohol 
Spectrum Disorders (FASD) more widely used at present. Further, the relationship with prenatal 
alcohol exposure and wider neurodevelopmental outcomes such as Autism and ADHD, whilst 
conceptualised, continues to be debated in terms of the nature of the relationship3 4. This lack of 
easy recognition, a lack of consistent diagnotic guidance and uncertain impact of prenatal alcohol 
between individuals all combine to lead to a high level of public health risk.  Actions to reduce the 
morbidity associated with FAS include prevention/reduction of alcohol exposure during pregnancy 
to prevent damage in the first place,  while lessening the morbidity for those with FASD also requires 
timely identification of cases and appropriate long term support for affected individuals. 
When considering the relationship of FASD to morbidity, which will include prevention of the 
condition alongside the individual and societal impact of the disorder, wider factors also have to be 
considered. Evidence from a 30-year cohort follow-up of diagnosed individuals identified significant 
levels of mental health problems, criminalisation, sexual exploitation as well as addictions in affected 
individuals1. A recent systematic review also identified 438 different ICD10 conditions linked to 
prenatal alcohol exposure5. This highlights the significant range of conditions that have been 
attributable to the effects of alcohol on the fetus. This morbidity often goes unattributed to prenatal 
alcohol therefore recognition of the impact of alcohol consumption during pregnancy is not made5. 
In order to begin addressing some of these issues it is important to understand what level of 
knowledge and information exists within both professionals and the public of FASD but also more 
detailed understanding as far as possible as to the types and range of disorders that are attributable. 
Studies from around the world, including studies in the UK, have identified that the level of 
knowledge about FASD is limited. Increasingly people have heard of the condition but, unlike 
conditions of arguably similar prevalence (e.g. autism), know little else about it. Professionals, public 
and carers of individuals with FASD all highlighted that there is a lack of knowledge and 
understanding broadly about FASD including appropriate care and support pathways for individuals 
who are affected6-8. Further, for many, labels are perceived to be stigmatising leading to an 
unwillingness to consider the diagnosis7. This in itself has an impact on accurate identification.  
Ascertaining prevalence   
May and Gossage9 summarise the common methods to assess prevalence. Passive systems, which 
are efficient for well recognised conditions that are easy to diagnose, are less useful for capturing 
the prevalence of FASD than they are for other more recognisable conditions, because the diagnosis 
is not obvious9. Diagnosis is dogged by difficulties, including the fact that many healthcare 
professionals know little about FASD and specialist training is needed to make a diagnosis. A 
diagnosis is generally made by a team of different professionals following a thorough assessment of 
the child that involves a physical examination, intelligence tests, occupational and physical therapy, 
and psychological, speech and neurological evaluations, as well as genetic tests to rule out genetic 
causes of problems10. Another difficulty with obtaining a diagnosis is that the behavioural and 
developmental problems typical of FASD may not emerge until a child is at primary school, and in 
some cases even later in life, by which time evidence about whether the birth mother drank during 
pregnancy, especially in the adopted or looked after childrens group, may be missing. This 
information is crucial to make a diagnosis if the distinctive facial features seen in full-blown FAS are 
not present. Another difficulty is that people with FASD often have other disorders (such as ADHD or 
autism spectrum disorder), making it difficult to isolate FASD. Moreover the condition rarely leads to 
a child being hospitalised, thus utilisation of hospital data sources is not reliable11 12. Clinic-based 
studies tend to follow up women during and after pregnancy, and are prospective, but a serious 
drawback with these is that FASD is diagnosed later in the child’s life9 12. Prevalence estimates using 
active case ascertainment are considered the ‘gold standard’ and, at their best, involve screening a 
cross section of the general population of children13. The substantial drawback to this method is the 
significant cost involved in conducting a rigorous study using active case ascertainment. 
A recent systematic review13 found 48 articles with data on 166 samples, most of which (81%) were 
from suspected high prevalence sub-populations, such as looked after children. Most studies were 
carried out in USA, Australia, Canada and South Africa. There were no UK studies. Among the 
samples based on the general population, the global prevalence of FAS was found to be 0.2% and 
FASD was estimated to be 2.3%, but the estimates for individual countries varied widely. Prevalence 
was highest in South Africa (FAS 5.5%; FASD 11.3%) and lowest in New Zealand (FAS 0.01%; no data 
for FASD). In the only two European countries for which there there were data, the prevlance of 
FASD was estimated to be 4.7% in Italy (with FAS 0.8%), while in Croatia there were no estimates for 
FASD but  FAS was estimated to be 1.1%. Of particular note, the study in Italy used active case 
ascertainment for the whole range of FASD and revealed a substantially higher prevalence than has 
previously been suspected14. Given that drinking levels in women of childbearing age are 
substantially higher in the UK compared to Italy (7 litres of pure alcohol in 2010 compared to under 4 
litres in Italy15), rates of prenatal exposure in the UK may be at least comparable to those elsewhere 
in Europe, if not higher.  
Hospital episode statistics from the UK and results of screening through a passive surveillance 
approach in Scotland have identified far lower levels of reported diagnosis than would be expected 
based on broader prevalence11 16. To date no specific prevalence study has been undertaken in the 
UK.  
Studies within specific subgroups show substantially higher prevalence include the following: 
Criminal Justice Settings 
Because the consequences of unsupported FASD include addiction, mental health problems, 
disengagement with education and inappropriate behaviour, many individuals with FASD find 
themselves in trouble with the law17. Thus, the criminal justice setting is likely to have a higher 
prevalence of individuals with FASD. A systematic review of studies carried out in  the criminal 
justice system (e.g. prisons) in 201118 found that all the studies had been carried out in either 
Canada (five studies) or USA (one). Studies using active case ascertainment (two Canadian studies) 
found prevalences of FASD substantially higher than the general population at 10.8% to 23.3%. A 
more recent systematic review to inform an analysis of the costs of FASD to the criminal justice 
system19 did not reveal any further more recent estimates for this vulnerable population. 
Looked after children 
Most of the emergent trends with ‘looked after’ children relate to data from international 
/transnational adoptions. For instance, children adopted from Central and Eastern Europe have 
often been reported to be prenatally exposed to alcohol19. A meta-analysis of studies published in 
201320 came up with a pooled estimate of 17% for FASD in child care settings (for studies using the 
gold standard method, active case ascertainment), ranging from 52% in children from Eastern 
Europe adopted by Swedish families to 0% in two studies (USA children adopted from China and 
Eastern European children adopted from Romania Ukraine and Moldovia). The pooled prevalence 
for FAS was 6%. Not included in the review was a study on mixed race looked after children in 
England, which showed a prevalence of 30%21. More recent studies confirm the very high prevalence 
rate in this group: 29% of looked after children referred for behavioural problems in Chicago, USA22; 
27% of looked after children referred for behavioural problems in Peterborough, UK23;  31% of 
children from Poland adopted to Dutch families24; and  17% children in a Brazilian orphanage25 had 
FASD.  
Alcohol use in pregnancy and its associated harms 
That heavy drinking during pregnancy can cause damage to the fetus, sometimes manifesting as FAS,  
is no longer controversial, but attempts to identify whether there is a safe threshold of drinking 
during pregnancy have not reported consistent findings.  A series of systematic reviews and meta-
analyses have examined the association between different drinking patterns, particularly light to 
moderate drinking and episodic or binge drinking, and a range of pregnancy and childhood 
outcomes26-31.Variously, individual studies have shown no association between moderate drinking 
during pregnancy and congenital anomaly31, no association between moderate drinking during 
pregnancy and a variety of pregnancy outcomes including miscarriage, stillbirth, prematurity or birth 
defects28, a small positive association between mild-to-moderate prenatal consumption and 
childhood cognition27, significant detrimental association between binge drinking prenatally and 
childhood cognition,27and no evidence of association between low-moderate consumption during 
pregnancy and speech and language outcomes29. Overall, these studies have not been able to show 
a relationship between low levels of alcohol consumption during pregnancy and adverse outcomes 
for the child30.  
Methodological limitations in the majority of the individual studies included in these reviews mean 
that they are not optimal to examine the association between low levels of drinking during 
pregnancy and FASD.  These include imprecise measures of exposure with most studies relying on 
self-report and not taking into account the triad of dose, pattern and timing of consumption32, 
alongside insufficiently discriminative assessment of outcome.  Many studies rely on educational 
achievement measures to represent neurodevelopmental deficit, many examine children at an age 
when these deficits may yet present, and few studies have fully assessed the full range of physical 
developmental characteristics which can be ascribed to FASD.  Perhaps most importantly, these 
studies are unable to account for all potential confounding factors: both before birth, e.g. 
concurrent substance misuse and exposure to other teratogens, and parental education and social 
class / networks; and after birth, particularly more psychosocial factors such as attachment styles.   
The limitations of traditional observational studies can be particularly highlighted when considering 
the findings from the well characterised Avon Longitudinal Study of Parents and Children (ALSPAC) 
study.   An observational analysis of children’s IQ at age 8 and educational achievement at age 11 
showed modest improvements in the children born to mothers who had consumed a moderate 
amount of alcohol during early pregnancy compared to mothers who had abstained, yet the quasi-
experimental method utilising Mendelian randomization on the same cohort showed that even small 
levels of alcohol consumption were associated with reduced educational attainment33. The authors 
argue that the positive association seen in the observational study reflected residual confounding 
with factors associated with maternal social position and education.   
This lack of knowledge of a “drinking harm threshold” in pregnancy has led to confusion in previous 
guildelines from both governments and professional bodies and only in 2016 has the chief medical 
officer of the UK revised guidelines on drinking in pregnancy to recommend that “women who are 
pregnant or planning a pregnancy should be advised that the safest approach is not to drink alcohol 
at all”.  This puts the UK in line with other countries including Canada, the USA, Australia, New 
Zealand, Denmark, France, Spain, the Netherlands and Ireland recommending abstinence in both 
pregnancy and the pre-conception period.   
A recent multi-national study, Screening for Pregnancy Endpoints (SCOPE), reports a substantial 
variation in the prevalence of reported alcohol consumption in pregnancy ranging from 40% of 
women in Australia, to 82% in Ireland34. In the UK, there is no standardised recording of alcohol 
exposure during pregnancy or the pre-conception period, despite it being stipulated in national 
antenatal care guidelines that this should be collected35.  Estimated alcohol consumption in the UK 
from SCOPE is 75% of women drinking at any time during pregnancy, with 33% of these women 
reporting at least one episode of binge drinking.  Arguably the best estimate of the consumption of 
alcohol during pregnancy in the UK comes from the infant feeding survey, last conducted in 201036 
This survey reports that 49% of mothers who drank before pregnancy gave up completely during 
their pregnancy, with a further 46% reducing their consumption.  This does however mask age-
related differences in drinking, with drinking more common in older mothers, and older mothers 
more likely to reduce their consumption rather than give up completely36 with similar demographic 
differentials displayed in more localised UK studies37.  
With an estimated half of all pregnancies being unplanned38 it is clear that even if guidelines 
recommending abstinence are heard and followed there is still a window of early pregnancy during 
which damage to the unborn fetus, unbeknownst to the mother, could occur.  Given that the 
harmful effects of alcohol are mediated both in early pregnancy during the development of the 
neural crest and organogenesis and throughout the remainder of pregnancy when neural pathways 
are being expanded, laid down and strengthened, women should be encouraged to reduce their 
consumption of alcohol at all stages of pregnancy regardless of when consumption is identified, in 
keeping with current UK guidance. 
 
 Prevention strategies  
On the basis of available published evidence, the country with the best developed approach to 
prevention of FASD is Canada10 39. The Canadian model divides prevention services into four levels, 
with level 1 comprising universal prevention initiatives, for example general education of pregnant 
women and the public about effects, including awareness campaigns and labelling on alcoholic 
products. Such interventions, that predominantly rely on education, are thought to be among the 
least effective alcohol interventions40; for example, a recent review suggests that labelling of 
alcoholic products may not be very effective41. Addressing the social and cultural determinants of 
alcohol consumption during pregnancy is imperative in order to prevent FASD, although relatively 
few interventions that take this approach have been subject to rigorous evaluation42.  
Selective prevention with non-pregnant women with risk factors such as substance misuse use 
issues, and mental ill-health and poverty form the second level of the Canadian model. In level 3, 
prevention is further focused using one-to-one contacts with pregnant women. Interventions to 
support this include: training of midwives; screening pregnant women for alcohol use and providing 
brief interventions if necessary; and treatment of alcohol addiction problems10.  The final tier of the 
Canadian model includes interventions that provide further support for those who have given birth 
but not changed their alcohol consumption, and this includes follow up and support for children. 
In the UK, policy around FASD is less well developed, though recent revised Department of 
Health guideline on alcohol now states that there is no safe alcohol limit for pregnant women (as 
above). This message now needs to be delivered consistently in a clinical setting10. Barriers to this 
may include midwives’ confidence to tackle alcohol consumption in pregnancy: recent UK research 
found that less than 2% of professionals who took part were 'very prepared to deal with the 
subject’43. The All Party Parliamentary Group on FASD, set up in 2015, calls for FASD to be at the 
forefront of the adoption process and the strengthening of healthcare professionals’ training and 
care pathways around FASD, and a focus on looked after children and the criminal justice systems44.   
Any serious attempt to prevent FASD would involve moving prevention efforts further upstream and 
should consider the wider context of pro-alcohol social norms in countries like the UK, and the need 
to reduce population-level alcohol consumption. The most effective ways of doing this is through 
action on price and availability of alcohol40 45. This is a step further than the Canadian model which 
stops short at ‘broad awareness building’ and ‘health promotion efforts’10. Another upstream 
prevention strategy would focus on the prevention of unintended pregnancies46, due to the high 
proportion of pregnancies that are unplanned38 and the high prevalence of alcohol consumption 
prior to knowledge of pregnancy47 (see above).  
 Training and whole system change  
Complexities exist with both recognising and identification of alcohol consumption risks as well as 
diagnosis of FASD. To modify this requires an almost whole system change in order to effect 
significant reductions in morbidity. For example, if at the antenatal stage alcohol consumption is not 
recognised and information adequately recorded, later in life it cannot be used in order to help 
facilitate a diagnosis. Going back even further into a more education and social setting outside the 
healthcare sector, if wider society does not recognise the impact of alcohol on the developing fetus 
and consumption rates remain at a high level harm may inadvertently occur. Because of the wide 
health impact of prenatal alcohol, a single approach is insufficient to address the problem. 
For many practitioners in multiple health and social care fields, the difficulties of recognition 
highlighted above are impacting on morbidity. For many, the lack of ability to first recognise and 
then manage the conditions, combined with the relatively limited evidence base in research for 
interventions, impacts on those affected. For example there is a clinical supposition that a FASD 
diagnosis in itself does not affect the management of the children, therefore making the diagnosis is 
not warranted. Yet, as shown, where recognition is made, even where other conditions such as 
ADHD are recognised as part of the wider profile, the FASD becomes an effect modifier to 
management3. Consenus guidance for the management of people with ADHD and FASD compared to 
those without FASD have recently been accepted for publication and will highlight the importance of 
recognising the differences further (ref).The need to understand that the cause of an outcome 
modifies the treatment approach seems to not be widely recognised7.  
The specific management should to be tailored to the individual, taking into account other factors 
including comorbid conditions, the indiviudal’s current and previous environment (e.g. whether 
adopted at birth from biological parent with history of alcohol abuse, remaining with birth parents 
or fostered/adopted later in childhood) and the timing of the diagnosis (e.g. as an infant, child or 
adult). The involvement of multiple disciplines to provide adequate, personalised services is 
essential. Promising interventions are available, although as yet these are not systematically applied 
in the UK to the same extent as they are, for example, in Canada. For example there are effective 
interventions that improve self-regulation and attentional control, social communication and 
behaviour (review by Reid et al. 2016).  
Finally, it is not sufficient to take an exclusively child focused approach without taking a wider, 
holistic approach, with consideration for the family. Hearing the parent voice is vital for psychosocial 
provision and optimising social support for child care (Phillips, 2015), and there is evidence that 
parent support programmes are effective in improving outcomes for parents (in terms of 
confidence, decreasing stress) and children (e.g. educational attainment, improvement in behaviour) 
(Reid et al., 2016).  
The only way for this knowledge to improve is for curriculae in many professional backgrounds to be 
developed, from university level upwards, to recognise and train people. Better integration into 
healthcare systems including supports between national, regional and local services, suggested by 
groups such as the BMA, when implemented into practice, make a difference to the support 
available both to professionals but also those affected. Based on the consensus meeting of 70 
professionals held in 2013 the BMA Board of Science recently updated their guidance highlighting 
pathways developed at the consensus meeting to identify, record information accurately, as well as 
follow-up individuals through to diagnosis10. In keeping with this approach to reduce morbidity both 
prevention and management are important. The burden of alcohol exposure has increased but 
exposure does not equate to necessary harm and stopping drinking early will generally always have 
a better outcome than continuing. There will yet be some people who despite stopping drinking 
during pregnancy, will give birth to affected children and understanding the needs of this group is 
also vital. 
 
Conclusions 
Reducing the morbidity associated with prenatal alcohol exposure is not a simple task, yet when 
considering both prevention and management of this condition, steps are being made.  The UK 
Parliamentary APPG on FASD published its report in 2015 identifying those stages and steps would 
be required in order to facilitate this system wide change44 and with increasing recognition, through 
education and involvement in curriculum both for schoolchildren, undergraduates and 
postgraduates of all associated specialties including non-healthcare specialties such as social work 
education, these long-term changes may well take place. Progress can already be seen for example, 
based simply on the number of reports, conferences and meetings taking place related to FASD in 
the UK compared to 10 years ago. The journey has begun but a long road is still yet to be trod if this 
preventable condition is to be adequately managed and the morbidity of this condition lessened.  
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